UK Meningitis Study CRF

Similar documents
CNS Infections. Philip Gothard Consultant in Infectious Diseases Hospital for Tropical Diseases, London. Hammersmith Acute Medicine 2011

ANTIBIOTIC GUIDELINES FOR THE MANAGEMENT OF COMMUNITY-ACQUIRED MENINGITIS AND ENCEPHALITIS IN ADULTS

GUIDELINE FOR THE MANAGEMENT OF MENINGITIS. All children with suspected or confirmed meningitis

Managing meningitis not just antibiotics. Helena White December 2013

Aetiology of meningitis at the Moi Teaching and Referral Hospital, Eldoret, Kenya. D. K. Lagat, MBChB, Mmed(Moi)

FILMARRAY: CAN IT MAKE A DIFFERENCE FOR CSF TESTING L O U I S E O S U L L I V A N, M M U H O S U L L I V A N M A T E R. I E

Viral Meningitis. 2. Use the information on the Possible Diseases sheet to complete the other four columns in the chart.

Union Theological Seminary Measles, Mumps & Rubella Form

Dilemmas in the Management of Meningitis & Encephalitis HEADACHE AND FEVER. What is the best initial approach for fever, headache, meningisums?

Cryptococcal Meningitis

Meningitis. A fact sheet for patients and carers

Central Nervous System Infection

Fever Without a Source Age: 0-28 Day Pathway - Emergency Department Evidence Based Outcome Center

The Child with HIV and a Fever 1

Brain abscess rupturing into the lateral ventricle causing meningitis: a case report

Syndromic Testing for Infectious Diseases

CNS INFECTIONS 1 Acute meningitis

Natural History of Untreated HIV-1 Infection

ID Emergencies. BGSMC Internal Medicine Edwin Yu

Dr Paul Holmes Guy s and St Thomas NHS Foundation Trust, London

Pneumococcal Meningitis Meningitis is an inflammation of the lining around the brain and spinal cord. Most severe cases

THE KEATS GROUP PRACTICE REGISTRATION FORM PLEASE COMPLETE IN BLOCK CAPITALS PERSONAL BACKGROUND INFORMATION

Emergency Neurological Life Support Meningitis and Encephalitis

IMPACT #: Local Inventory #: form 04. Age at admission: d. mo yr. Postal code:

Symptoms of meningism and raised numbers of cells in the CSF with a sterile bacterial culture.

Cerebrospinal Fluid in CNS Infections

35.0. ug/ml Trough. 8.0 Carbamazepine 15.0 ug/ml Digoxin 2.5 ng/ml Gentamicin Peak Random Trough

HEALTH OFFICE, Poughkeepsie, NY Residential Student:

ID Emergencies. BUMC-P Internal Medicine Edwin Yu

Local Public Health Department. Communicable diseases Environmental health Chronic diseases Emergency preparedness Special programs

Case presentation. Dr REESAUL R

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Summary. Meningitis. Meningitis. Conflicts of interests. Meningitis what s new?

MANAGEMENT OF SUSPECTED VIRAL ENCEPHALITIS IN CHILDREN

2016 Vaccine Preventable Disease Summary

KAP conference 19 th March 2008: Dr Mohamed Hussein Jin.

ICM VI-09 DEFINITION REFERENCES

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

Community-acquired meningitis encompasses a broad

4/24/2013. Haemophilus influenzae Meningitis. Neisseria Meningitis. Streptococcus pneumoniae Meningitis

Nottingham Children s Hospital

CNS Infections in the Pediatric Age Group

Surveillance for encephalitis in Bangladesh: preliminary results

A rash case Infection control management of measles

Meningitis. Matthew Grant MD

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

Profile of Cerebrospinal Fluid Analysis in Acute Central Nervous System Infections

BACTERIAL MENINGITIS: A FIVE YEAR ( ) RETROSPECTIVE STUDY AT UNIVERSITY MALAYA MEDICAL CENTer (UMMC), KUALA LUMPUR, MALAYSIA

Good Morning! Welcome Applicants! FRIDAY, N OVEMBER, 7 TH 2014

Class 15. Infections of the Central Nervous System

2015 Vaccine Preventable Disease Summary

REQUIRED IMMUNIZATIONS

PEACEHEALTH LABORATORIES

MICROBIOLOGICAL TESTING IN PICU

Supplementary Appendix

INVASIVE MENINGOCOCCAL DISEASE (IMD), OTHER BACTERIAL MENINGITIS, HAEMOPHILUS INFLUENZAE & VIRAL MENINGITIS INFECTIONS IN IRELAND

Aurora Health Care South Region EMS st Quarter CE Packet

Investigation of a Neisseria meningitidis Serogroup A Case in the Meningitis Belt. January 2017

Advanced HIV and seriously ill: challenges in low resource settings Rosie Burton, Southern African Medical Unit, MSF

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

Class time required: Four forty minute class periods. Parts 1 and 4 could be assigned as homework but Parts 2 and 3 should be completed in class.

New Technique uses to Evaluate Cerebrospinal Fluid Lactic Acid as an Aid Differential Diagnosis of Bacterial and Viral Meningitis

Medical monitoring: tests available at central hospitals

Fever in the Newborn Period

Vaccine Preventable Diseases. Overview MEASLES 4/8/2015. Amy Schwartz, MPH Immunization Surveillance Coordinator North Dakota Department of Health

When the drugs don t work- a case of HSV encephalitis.

May He Rest in Peace

CNS INFECTIONS MENINGITIS

VIRAL ENCEPHALITIS EASY TO MISS

Meningococcal Disease and College Students

enter the room. Persons immune from previous varicella infection may enter the room without a mask. Those immune by adenoviruses, influenza viruses.

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

Guidelines for the Immediate Management of Paediatric Patients with Sickle Cell Disease (SCD) and Acute Neurological Symptoms

Faculty Disclosure. Stephen I. Pelton, MD. Dr. Pelton has listed no financial interest/arrangement that would be considered a conflict of interest.

Pneumococcal Disease and Pneumococcal Vaccines

INVASIVE MENINGOCOCCAL DISEASE (IMD), BACTERIAL/VIRAL MENINGITIS & HAEMOPHILUS INFLUENZAE INFECTIONS IN IRELAND

National Institute for Communicable Diseases -- Weekly Surveillance Report --

Opportunistic Infections BHIVA Guidelines

Aseptic meningitis in a patient taking etanercept for rheumatoid arthritis: a case report

CAMP GUGGENHEIM. Update March 2018

Aetiology Viruses are the most common cause of meningitis, and are often less serious than bacterial or fungal forms of the disease.

JMSCR Vol 04 Issue 07 Page July 2016

Approach to the critically ill patient with advanced HIV in low resource settings. Sebastian Albus, MD MSF, Operational Center Bruxelles

NOTICE OF IMMUNIZATION REQUIREMENTS

If these vaccines haven t been given, please follow guidelines below for emergency procedures.

Bacterial meningitis

It is my pleasure to welcome you to Harvard University Health Services.

NeisVac-C Meningococcal group C polysaccharide conjugate vaccine (tetanus toxoid protein conjugate)

4/14/2010. Theoretical purpose of fever? Andrea Marmor, MD, MSEd Assistant Clinical Professor, Pediatrics UCSF April 13, 2010

Appropriate utilization of the microbiology laboratory. 11 April 2013

Rapid and progressive necrosis of the tissue underlying epidermis (cellulitis)

Cerebral Toxoplasmosis in HIV-Infected Patients. Ahmed Saad,MD,FACP

Title: Cost of Managing Meningitis and Encephalitis among Adult Patients in the United States

Fevers and Seizures in Infants and Young Children

The Diagnostic Accuracy of Kernig s Sign, Brudzinski s Sign, and Nuchal Rigidity in Adults with Suspected Meningitis

Name: RUID: Last, First MI This section is to be completed by the students' licensed healthcare provider. VACCINE Dose #1 Date

Fever in children aged less than 5 years

Beyond the Reflex Arc: An Evidence-Based Discussion of the Management of Febrile Infants

Methods of rapid diagnosis for the etiology of meningitis in adults

Transcription:

History Date of onset of symptoms Route of admission A and E GP Other Date of admission to hospital* / / Time of admission (24 hour clock) : *record time and date of admission to A and E if admitted ia A and E Did the patient hae any of the following symptoms? Feer or history of feer Yes Duration (hours) No Unknown Headache Yes Duration (hours) No Unknown Neck Stiffness Yes Duration (hours) No Unknown Photophobia Yes Duration (hours) No Unknown Diarrhoea Yes Duration (hours) No Unknown Nausea Yes Duration (hours) No Unknown Vomiting Yes Duration (hours) No Unknown Myalgia Yes Duration (hours) No Unknown Rash Yes Duration (hours) No Unknown Confusion Yes Duration (hours) No Unknown Seizures Yes Duration (hours) No Unknown Cough Yes Duration (hours) No Unknown Weight Loss Yes Duration (hours) No Unknown Night sweats Yes Duration (hours) No Unknown Any other significant symptoms please document below: Vaccination history Has the patient receied any of the following accinations? Pneumococcal PPV 23 Y N If yes when (year) Pneumococcal PCV 13 Y N If yes when (year) Pneumococcal PCV 7 Y N If yes when (year) Pneumococcal accine unknown type Y N If yes when (year) Meningococcal C Y N If yes when (year) Meningococcal ACWY Y N If yes when (year) Meningococcal B Y N If yes when (year) Meningococcal accine unknown type Y N If yes when (year) Haemophilus influenzae type B Y N If yes when (year) Page 1 of 9

Trael history Has the patient traelled to any of the following places in the last 12 months? India Y N How long was the patient resident there? Bangladesh Y N How long was the patient resident there? Pakistan Y N How long was the patient resident there? Sub Saharan Africa Y N How long was the patient resident there? Has the patient traelled anywhere else outside the UK in the last 12 months? Y N Unknown If yes, where? and when did they return (month and year)? (please enter 01 if exact day unknown) Has the patient eer lied outside the UK? Y N Unknown If so where? When did they moe to the UK (month and year OR year)? _/ Ethnicity White British Irish Other White Asian or Asian British Indian Pakistani Bangladeshi Chinese Other Asian Black or Black British Caribbean African Other Black Mixed White and Black Caribbean White and Black African White and Asian Other Mixed Other ethnic group Examination On examination did the patient hae any of the following? Photophobia Y N Unknown Neck Stiffness Y N Unknown Rash Y N Unknown Any focal neurology Y N Unknown If focal neurology was present please expand in box below What was the patient s GCS on admission (lowest alue recorded in first 24 hours) What was the patient s temperature on admission (highest alue in first 24 hours) Page 2 of 9

Blood results (record results nearest to date of admission) WCC. x10 9 /L Neuts. x10 9 /L Lymphs. x10 9 /L Platelets. x 10 9 /L Hb. g/dl (if the result at your site is in g/l please diide by 10 before inserting the alue here) CRP < 10mg/L OR mg/l Procalcitonin. ng/ml Sodium mmol/l PT. seconds OR INR. APTT. seconds Blood Cultures Were blood cultures taken? Y N Date and time first set of blood cultures were taken? Date / / Time (24h) : Was blood culture positie Y N Blood Gram Film Result Not done No organisms seen Yeast Gram positie cocci?strep Gram positie cocci?staph Gram negatie cocci Gram positie bacilli Gram negatie bacilli Other (expand below) Blood Culture Result No growth Streptococcus pneumoniae^ Neisseria meningitidis^ Listeria monocytogenes^ Haemophilus influenzae^ Cryptococcus neoformans Staphylococcus aureus Escherichia coli Other (please state below) ^Please record serotype/serogroup Blood PCR Meningococcal PCR Pos Neg Not done Date / / Time (24h) Please record serotype if positie Pneumococcal PCR Pos Neg Not done Date / / Time (24h) Any other PCR on blood Pos Neg Please state which below (including 16S and result) Page 3 of 9

CSF results Did the patient hae an LP? Y N If no, please gie reasons: Unsuccessful attempts Clinical contraindication Patient refused LP no longer clinically indicated after enrolment Other (please state below) Date and time of lumbar puncture Date Time (24h) Opening pressure. cm CSF Not done White cells <5 or per mm 3 or x10 6 /L Red cells <1 or per mm 3 or x10 6 /L Lymphocytes % Neutrophils/Polymorphs % Protein. g/l CSF glucose. mmol/l Not done Concurrent blood glucose**. mmol/l Date taken Time (24h) (**must be taken within 4 hours of the LP, record capillary BM if lab glucose not done) Gram Film result Not done No organisms seen Yeast Gram positie cocci?strep Gram positie cocci?staph Gram negatie cocci Gram positie bacilli Gram negatie bacilli Other (expand below) Other: Microscopy for AFBs Auramine Positie Negatie Not done Ziehl Neilsen Positie Negatie Not done CSF Culture result No growth Streptococcus pneumoniae^ Neisseria meningitidis^ Listeria monocytogenes^ Haemophilus influenzae^ Mycobacterium tuberculosis Cryptococcus neoformans Staphylococcus aureus Escherichia coli Other (please state) ^Please record serotype/serogroup Page 4 of 9

CSF PCR results Meningococcal ^ Positie Negatie Not done Pneumococcal Positie Negatie Not done HSV-1 Positie Negatie Not done HSV-2 Positie Negatie Not done Enteroirus^ Positie Negatie Not done VZV Positie Negatie Not done Mycobacterium tuberculosis Positie Negatie Not done Other (please state) ^Please record typing of any PCR positie for meningococci or enteroirus Other inestigations Viral throat swab (enteroirus PCR) Positie Negatie Not done Stool sample/rectal swab (enteroirus PCR) Positie Negatie Not done HIV Test Known HIV Positie Negatie Not done Cryptococcal antigen Positie Negatie Not done Bacterial throat swab for culture Positie Negatie Not done If bacterial throat swab positie please state for what Please document any other clinically significant diagnostic inestigations below (including any further serological testing). Page 5 of 9

Imaging (please send all reports of abnormal scans to the Brain Infections office anonymised) Did the patient hae a CXR performed? Yes No Unknown If yes: what was the date and time of CXR? Date Time (24h) Was the CXR Normal Abnormal Did the CXR show any features of acute pulmonary tuberculosis? Yes No Did the CXR show any features of miliary TB? Yes No Please expand on any abnormalities Did the patient hae a CT head performed? Yes No Unknown If yes: what was the date and time of CT? Date Time (24h) Was the CT Normal Abnormal Please expand on any abnormalities Did the patient hae an MRI head performed? Yes No Unknown If Yes: What was the date and time of MRI? Date Time (24h) Was the MRI Normal Abnormal Please expand on any abnormalities If any of the aboe inestigations were abnormal please fax or scan an anonymised ersion of the releant inestigation to the UK Meningitis team. Page 6 of 9

Treatment Is the patient allergic to any antibiotics Yes No Not documented Please document any antibiotic allergies below with reaction Preadmission antimicrobials Were antibiotics gien prior to admission? Yes No If yes, who prescribed/gae them? GP A and E Paramedic Other (please state) Date and time gien/started Date Time (24h) What antibiotic was gien? Ceftriaxone/cefotaxime Benzylpenicillin Amoxicillin Other If other, please state which By what route were the antibiotics gien? IV IM Oral How many doses did the patient hae before admission? Was the patient on acicloir/alacicloir prior to admission? Yes No If yes, what dose and when was this started? Please document all treatment gien for meningitis (including any gien on discharge) (include antibiotics, antiirals and steroid therapy). Name Route Dose Frequency Date and time of first dose Duration (no of doses) Page 7 of 9

Final Diagnosis What was the final diagnosis as recorded on the discharge letter? Which of the following was the final diagnostic category? (See Final Diagnostic Category Cribsheet) Not meningitis other iral illness Not meningitis other bacterial illness Not meningitis migraine/headache Not meningitis other Enteroiral meningitis Herpes simplex meningitis Varicella meningitis Other proen iral meningitis Pneumococcal meningitis Meningococcal meningitis Other proen bacterial meningitis Presumed iral meningitis Presumed bacterial meningitis TB meningitis Other meningitis Encephalitis Unknown Date of discharge/death from hospital / / Did the patient die? Yes No Did the patient need ITU care? Yes No If yes how long for (days)? Please record any other releant comments below Outcomes Glasgow Coma Scale on Discharge Referring to descriptors below please record the Modified Rankin Scale on admission and at discharge. Modified Rankin Scale Admission Discharge 0 No symptoms at all 1 No significant disability despite symptoms; able to carry out all usual duties and actiities 2 Slight disability; unable to carry out all preious actiities, but able to look after own affairs without assistance 3 Moderate disability; requiring some help, but able to walk without assistance 4 Moderately seere disability; unable to walk without assistance and unable to attend to own bodily needs without assistance 5 Seere disability; bedridden, incontinent and requiring constant nursing care and attention 6 Dead Referring to descriptors below please record the Glasgow Outcome Score on discharge. GOS on discharge? 1 Good Recoery Capacity to resume normal occupational and social actiities, although there may be minor physical or mental deficits or symptoms 2 Moderate Disability Independent and can resume almost all actiities of daily liing. Disabled to the extent that they cannot participate in a ariety of social and work actiities 3 Seere Disability No longer capable of engaging in most preious personal, social or work actiities. Limited communication skills and hae abnormal behaioural or emotional responses. Typically are partially or totally dependent on assistance from others in daily liing 4 Persistent Vegetatie State Not aware of surroundings or purposely responsie to stimuli 5 Dead Page 8 of 9

Optional Samples Substudies 6.9.3, 6.9.4 and 6.9.5. Has the patient consented to haing extra sample of blood/csf taken for research purposes? Yes No If yes, has the patient had samples taken for (please tick): Study Sample Tube Amount Taken Date Taken Time Taken Biomarkers of infection Blood PaxGene (at recruitment) 2.5ml Blood PaxGene (at 3-5 days) 2.5ml CSF PaxGene 2.5ml Proteomics Blood EDTA 4.5ml DNA Sampling Blood EDTA 18ml CSF Plain 3-5ml Serum sample Blood Clotted sample 3-5ml Has leftoer CSF been located and stored? Yes No Any comments re sampling/storage? (Please use this box to record the approximate amount of samples stored if known.) Page 9 of 9